Selected research
Industry Research
Nonclinical Safety Assessment Service Industry Research Report 2026
Market perspective
The global Nonclinical Safety Assessment Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nonclinical Safety Assessment Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nonclinical Safety Assessment Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nonclinical Safety Assessment Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nonclinical Safety Assessment Service include WuXi AppTec, Joinn Laboratories, Innoscience, Westchina-Frontier Pharma Tech, Pharmaron, Gradient, Biopharma Excellence, Evotec and Charles River, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nonclinical Safety Assessment Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nonclinical Safety Assessment Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nonclinical Safety Assessment Service Market by Company
WuXi AppTec
Joinn Laboratories
Innoscience
Westchina-Frontier Pharma Tech
Pharmaron
Gradient
Biopharma Excellence
Evotec
Charles River
labcorp
CellPurics
Medicilon
Nonclinical Safety Assessment Service Segment by Type
Safety Assessment for Drug
Safety Assessment for Medical Devices
Nonclinical Safety Assessment Service Segment by Application
Pharmaceutical Companies
Biotechnology Companies
CRO
Others
Nonclinical Safety Assessment Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonclinical Safety Assessment Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nonclinical Safety Assessment Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonclinical Safety Assessment Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nonclinical Safety Assessment Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Safety Assessment for Drug
- Safety Assessment for Medical Devices
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- CRO
- Others
Companies covered
- WuXi AppTec
- Joinn Laboratories
- Innoscience
- Westchina-Frontier Pharma Tech
- Pharmaron
- Gradient
- Biopharma Excellence
- Evotec
- Charles River
- labcorp
- CellPurics
- Medicilon
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nonclinical Safety Assessment Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Safety Assessment for Drug
- 2.2.3 Safety Assessment for Medical Devices
- 2.3 Nonclinical Safety Assessment Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Biotechnology Companies
- 2.3.4 CRO
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Nonclinical Safety Assessment Service Breakdown Data by Type
- 3.1 Global Nonclinical Safety Assessment Service Historic Market Size by Type (2021-2026)
- 3.2 Global Nonclinical Safety Assessment Service Forecasted Market Size by Type (2027-2032)
4 Nonclinical Safety Assessment Service Breakdown Data by Application
- 4.1 Global Nonclinical Safety Assessment Service Historic Market Size by Application (2021-2026)
- 4.2 Global Nonclinical Safety Assessment Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nonclinical Safety Assessment Service Market Perspective (2021-2032)
- 5.2 Global Nonclinical Safety Assessment Service Growth Trends by Region
- 5.2.1 Global Nonclinical Safety Assessment Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nonclinical Safety Assessment Service Historic Market Size by Region (2021-2026)
- 5.2.3 Nonclinical Safety Assessment Service Forecasted Market Size by Region (2027-2032)
- 5.3 Nonclinical Safety Assessment Service Market Dynamics
- 5.3.1 Nonclinical Safety Assessment Service Industry Trends
- 5.3.2 Nonclinical Safety Assessment Service Market Drivers
- 5.3.3 Nonclinical Safety Assessment Service Market Challenges
- 5.3.4 Nonclinical Safety Assessment Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nonclinical Safety Assessment Service Players by Revenue
- 6.1.1 Global Top Nonclinical Safety Assessment Service Players by Revenue (2021-2026)
- 6.1.2 Global Nonclinical Safety Assessment Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Nonclinical Safety Assessment Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nonclinical Safety Assessment Service Head Office and Area Served
- 6.4 Global Nonclinical Safety Assessment Service Players, Product Type & Application
- 6.5 Global Nonclinical Safety Assessment Service Manufacturers Established Date
- 6.6 Global Nonclinical Safety Assessment Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nonclinical Safety Assessment Service Market Size (2021-2032)
- 7.2 North America Nonclinical Safety Assessment Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nonclinical Safety Assessment Service Market Size by Country (2021-2026)
- 7.4 North America Nonclinical Safety Assessment Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nonclinical Safety Assessment Service Market Size (2021-2032)
- 8.2 Europe Nonclinical Safety Assessment Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nonclinical Safety Assessment Service Market Size by Country (2021-2026)
- 8.4 Europe Nonclinical Safety Assessment Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nonclinical Safety Assessment Service Market Size (2021-2032)
- 9.2 Asia-Pacific Nonclinical Safety Assessment Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nonclinical Safety Assessment Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nonclinical Safety Assessment Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nonclinical Safety Assessment Service Market Size (2021-2032)
- 10.2 South America Nonclinical Safety Assessment Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nonclinical Safety Assessment Service Market Size by Country (2021-2026)
- 10.4 South America Nonclinical Safety Assessment Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nonclinical Safety Assessment Service Market Size (2021-2032)
- 11.2 Middle East & Africa Nonclinical Safety Assessment Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nonclinical Safety Assessment Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nonclinical Safety Assessment Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 WuXi AppTec
- 12.1.1 WuXi AppTec Company Information
- 12.1.2 WuXi AppTec Business Overview
- 12.1.3 WuXi AppTec Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.1.4 WuXi AppTec Nonclinical Safety Assessment Service Product Portfolio
- 12.1.5 WuXi AppTec Recent Developments
- 12.2 Joinn Laboratories
- 12.2.1 Joinn Laboratories Company Information
- 12.2.2 Joinn Laboratories Business Overview
- 12.2.3 Joinn Laboratories Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.2.4 Joinn Laboratories Nonclinical Safety Assessment Service Product Portfolio
- 12.2.5 Joinn Laboratories Recent Developments
- 12.3 Innoscience
- 12.3.1 Innoscience Company Information
- 12.3.2 Innoscience Business Overview
- 12.3.3 Innoscience Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.3.4 Innoscience Nonclinical Safety Assessment Service Product Portfolio
- 12.3.5 Innoscience Recent Developments
- 12.4 Westchina-Frontier Pharma Tech
- 12.4.1 Westchina-Frontier Pharma Tech Company Information
- 12.4.2 Westchina-Frontier Pharma Tech Business Overview
- 12.4.3 Westchina-Frontier Pharma Tech Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.4.4 Westchina-Frontier Pharma Tech Nonclinical Safety Assessment Service Product Portfolio
- 12.4.5 Westchina-Frontier Pharma Tech Recent Developments
- 12.5 Pharmaron
- 12.5.1 Pharmaron Company Information
- 12.5.2 Pharmaron Business Overview
- 12.5.3 Pharmaron Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.5.4 Pharmaron Nonclinical Safety Assessment Service Product Portfolio
- 12.5.5 Pharmaron Recent Developments
- 12.6 Gradient
- 12.6.1 Gradient Company Information
- 12.6.2 Gradient Business Overview
- 12.6.3 Gradient Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.6.4 Gradient Nonclinical Safety Assessment Service Product Portfolio
- 12.6.5 Gradient Recent Developments
- 12.7 Biopharma Excellence
- 12.7.1 Biopharma Excellence Company Information
- 12.7.2 Biopharma Excellence Business Overview
- 12.7.3 Biopharma Excellence Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.7.4 Biopharma Excellence Nonclinical Safety Assessment Service Product Portfolio
- 12.7.5 Biopharma Excellence Recent Developments
- 12.8 Evotec
- 12.8.1 Evotec Company Information
- 12.8.2 Evotec Business Overview
- 12.8.3 Evotec Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.8.4 Evotec Nonclinical Safety Assessment Service Product Portfolio
- 12.8.5 Evotec Recent Developments
- 12.9 Charles River
- 12.9.1 Charles River Company Information
- 12.9.2 Charles River Business Overview
- 12.9.3 Charles River Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.9.4 Charles River Nonclinical Safety Assessment Service Product Portfolio
- 12.9.5 Charles River Recent Developments
- 12.10 labcorp
- 12.10.1 labcorp Company Information
- 12.10.2 labcorp Business Overview
- 12.10.3 labcorp Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.10.4 labcorp Nonclinical Safety Assessment Service Product Portfolio
- 12.10.5 labcorp Recent Developments
- 12.11 CellPurics
- 12.11.1 CellPurics Company Information
- 12.11.2 CellPurics Business Overview
- 12.11.3 CellPurics Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.11.4 CellPurics Nonclinical Safety Assessment Service Product Portfolio
- 12.11.5 CellPurics Recent Developments
- 12.12 Medicilon
- 12.12.1 Medicilon Company Information
- 12.12.2 Medicilon Business Overview
- 12.12.3 Medicilon Revenue in Nonclinical Safety Assessment Service Business (2021-2026)
- 12.12.4 Medicilon Nonclinical Safety Assessment Service Product Portfolio
- 12.12.5 Medicilon Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst